1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Lifecome Biochemistry Co.,Ltd.

Lifecome Biochemistry Co.,Ltd.

002868.SZ
Lifecome Biochemistry Co.,Ltd.CN flagShenzhen Stock Exchange
27.37
CNY
-0.73
- -
4.25BMarket Cap

Total Valuation

Lifecome Biochemistry Co.,Ltd. carries a market capitalization of 4.25B, placing it among publicly traded companies globally. Its enterprise value stands at 4.60B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.25B
Enterprise Value4.60B

Share Statistics

Lifecome Biochemistry Co.,Ltd. currently has 155.42M shares outstanding.

Shares Outstanding155.42M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 6.07, and the price-to-book ratio stands at -7.57.

PE RatioN/A
PS Ratio6.07
PB Ratio-7.57
P/TBV Ratio-18.70
P/FCF Ratio100.45
P/OCF RatioN/A

Enterprise Valuation

EV / Sales7.45
EV / EBITDAN/A
EV / EBITN/A
EV / FCF44.31

Financial Position

Lifecome Biochemistry Co.,Ltd. maintains a current ratio of 0.14, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,066.63, indicating conservative leverage, while an interest coverage ratio of -2.07 demonstrates limited ability to service its debt obligations.

Current Ratio0.14
Quick Ratio0.01
Debt / Equity-1,066.63
Debt / EBITDA-7.09
Interest Coverage-2.07

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-26.34
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.83

Taxes

Income Tax46.60M
Effective Tax RateN/A

Stock Price Statistics

Lifecome Biochemistry Co.,Ltd.'s stock has gained approximately 14.32749% over the past 52 weeks. The 50-day moving average sits at 37.00, while the 200-day moving average is 34.84.

Beta (5Y)N/A
52-Week Price Change14.32749%
50-Day Moving Average37.00
200-Day Moving Average34.84
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Lifecome Biochemistry Co.,Ltd. generated 616.82M in revenue and converted that into -416.36M in net income, yielding earnings per share of -2.69. EBITDA reached -122.24M, while operating income came in at -122.24M.

Revenue616.82M
Gross Profit-36.83M
Operating Income-122.24M
Pretax Income-370.17M
Net Income-416.36M
EBITDA-122.24M
EBIT-122.24M
Earnings Per Share (EPS)-2.69

Balance Sheet

Lifecome Biochemistry Co.,Ltd. holds 15.88M in cash and equivalents against 866.45M in total debt, resulting in a net debt position of 267.43M. Total book value stands at -494.90M, with working capital of -1.05B providing operational flexibility.

Cash & Cash Equivalents15.88M
Total Debt866.45M
Net Debt267.43M
Equity (Book Value)-494.90M
Book Value Per Share-3.20
Working Capital-1.05B

Cash Flow

After subtracting -37.29M in capital expenditures, free cash flow totaled -37.29M - equivalent to -0.24 per share.

Operating Cash FlowN/A
Capital Expenditures-37.29M
Free Cash Flow-37.29M
FCF Per Share-0.24

Margins

Lifecome Biochemistry Co.,Ltd. operates with a gross margin of -5.97, reflecting its pricing power and cost economics. The operating margin of -19.82 and net profit margin of -67.50 provide insight into operational efficiency.

Gross Margin-5.97
Operating Margin-19.82
Pretax Margin-60.01
Profit Margin-67.50
EBITDA Margin-19.82

Dividends & Yields

The company's payout ratio of -11.32 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.31
Dividend YieldN/A
Payout Ratio-11.32
Shareholder Yield2.22
FCF Yield1.00

Stock Splits

Lifecome Biochemistry Co.,Ltd.'s most recent stock split took place on May 28, 2020 with a 10:13 split ratio.

Last Split Date5/28/2020
Split Ratio10:13

Scores

Lifecome Biochemistry Co.,Ltd. posts an Altman Z-Score of -0.01, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.01